References
Duvic M., Martin A., Hymes K., et al. Oral bexarotene capsules as treatment for all stages of refractory or persistent CTCL [abstract no. 150]. J Invest Dermatol 2000 114: 776
Smit J., de Jong E., van Hooijdonk C., et al. A multicentre phase II clinical and immunohistochemical trial of systemic bexarotene (Targretin) in psoriasis [abstract no. 151]. J Invest Dermatol 2000, 114: 776
Boehm M.F., Heyman R.A., Patel S., et al. Retinoids: Biological function and use in the treatment of dermatological diseases. Expert Opin Invest Drug 1995, 4: 593–612
Fox F.E., Kubin M., Cassin M., et al. Retinoids synergize with interleukin-2 to augment interferon gamma and interleukin-12 production by human peripheral blood mononuclear cells. J Interferon Res 1999, 19: 407–415
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rook, A.H., Lehrer, M.S., Junkins-Hopkins, J.M. et al. Bexarotene. Am J Clin Dermatol 1, 251 (2000). https://doi.org/10.2165/00128071-200001040-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200001040-00007